Literature DB >> 31069156

TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.

Tatsuo Matsuda1,2,3, Eisaku Miyauchi1, Yu-Wen Hsu1,4, Satoshi Nagayama5, Kazuma Kiyotani6, Makda Zewde1, Jae-Hyun Park1, Taigo Kato1, Makiko Harada1, Shimpei Matsui5, Masashi Ueno5, Kazumasa Fukuda2, Nobuaki Suzuki7, Shoichi Hazama7, Hiroaki Nagano7, Hiroya Takeuchi2,8, Wickii T Vigneswaran9, Yuko Kitagawa2, Yusuke Nakamura1,6.   

Abstract

Tumor draining lymph nodes (TDLNs) are located in the routes of lymphatic drainage from a primary tumor and have the highest risk of metastasis in various types of solid tumors. TDLNs are also considered as a tissue to activate the antitumor immunity, where antigen-specific effector T cells are generated. However, T cell receptor (TCR) repertoires in TDLNs have not been well characterized. We collected 23 colorectal cancer tumors with 203 lymph nodes with/without metastatic cancer cells (67 were metastasis-positive and the remaining 136 were metastasis-negative) and performed TCR sequencing. Metastasis-positive TDLNs showed a significantly lower TCR diversity and shared TCR clonotypes more frequently with primary tumor tissues compared to metastasis-negative TDLNs. Principal component analysis indicated that TDLNs with metastasis showed similar TCR repertoires. These findings suggest that cancer-reactive T cell clones could be enriched in the metastasis-positive TDLNs.

Entities:  

Keywords:  T cell receptor; colorectal cancer; immunogenomics; immunotherapy; lymph node

Year:  2019        PMID: 31069156      PMCID: PMC6492974          DOI: 10.1080/2162402X.2019.1588085

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  44 in total

Review 1.  The tumor-draining lymph node as an immune-privileged site.

Authors:  David H Munn; Andrew L Mellor
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 2.  How T cells 'see' antigen.

Authors:  Michelle Krogsgaard; Mark M Davis
Journal:  Nat Immunol       Date:  2005-03       Impact factor: 25.606

3.  High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.

Authors:  Sytse J Piersma; Ekaterina S Jordanova; Mariëtte I E van Poelgeest; Kitty M C Kwappenberg; Jeanette M van der Hulst; Jan W Drijfhout; Cornelis J M Melief; Gemma G Kenter; Gert Jan Fleuren; Rienk Offringa; Sjoerd H van der Burg
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 4.  Tumour-induced immune modulation of sentinel lymph nodes.

Authors:  Alistair J Cochran; Rong-Rong Huang; Jonathan Lee; Eijun Itakura; Stanley P L Leong; Richard Essner
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

5.  Methods for comparing the diversity of samples of the T cell receptor repertoire.

Authors:  Vanessa Venturi; Katherine Kedzierska; Stephen J Turner; Peter C Doherty; Miles P Davenport
Journal:  J Immunol Methods       Date:  2007-02-21       Impact factor: 2.303

6.  Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.

Authors:  Yukihiro Funada; Tsuyoshi Noguchi; Ryuichi Kikuchi; Shinsuke Takeno; Yuzo Uchida; Helmut E Gabbert
Journal:  Oncol Rep       Date:  2003 Mar-Apr       Impact factor: 3.906

7.  Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer.

Authors:  Mona Karlsson; Per Marits; Kjell Dahl; Tobias Dagöö; Sven Enerbäck; Magnus Thörn; Ola Winqvist
Journal:  Ann Surg Oncol       Date:  2010-01-30       Impact factor: 5.344

Review 8.  The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

Authors:  M J M Gooden; G H de Bock; N Leffers; T Daemen; H W Nijman
Journal:  Br J Cancer       Date:  2011-05-31       Impact factor: 7.640

9.  Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer.

Authors:  P Marits; M Karlsson; K Dahl; P Larsson; A Wanders; M Thörn; O Winqvist
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  8 in total

1.  Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma.

Authors:  Booyeon J Han; Joseph D Murphy; Shuyang Qin; Jian Ye; Taylor P Uccello; Jesse Garrett-Larsen; Brian A Belt; Peter A Prieto; Nejat K Egilmez; Edith M Lord; David C Linehan; Bradley N Mills; Scott A Gerber
Journal:  Immunol Invest       Date:  2020-06-04       Impact factor: 3.657

2.  Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer.

Authors:  Xiaofan Mao; Dan Zhou; Kairong Lin; Beiying Zhang; Juntao Gao; Fei Ling; Lewei Zhu; Sifei Yu; Peixian Chen; Chuling Zhang; Chunguo Zhang; Guolin Ye; Simon Fong; Guoqiang Chen; Wei Luo
Journal:  Cancer Immunol Immunother       Date:  2022-08-30       Impact factor: 6.630

3.  Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.

Authors:  Teng Wei; Matthias Leisegang; Ming Xia; Kazuma Kiyotani; Ning Li; Chenquan Zeng; Chunyan Deng; Jinxing Jiang; Makiko Harada; Nishant Agrawal; Liangping Li; Hui Qi; Yusuke Nakamura; Lili Ren
Journal:  Oncoimmunology       Date:  2021-05-25       Impact factor: 8.110

4.  A T cell repertoire timestamp is at the core of responsiveness to CTLA-4 blockade.

Authors:  Hagit Philip; Tom Snir; Miri Gordin; Mikhail Shugay; Alona Zilberberg; Sol Efroni
Journal:  iScience       Date:  2021-01-27

Review 5.  Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.

Authors:  Hiroyasu Aoki; Shigeyuki Shichino; Kouji Matsushima; Satoshi Ueha
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

6.  The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis.

Authors:  YiHeng Du; WenHao Miao; Xiang Jiang; Jin Cao; Bo Wang; Yi Wang; Jiang Yu; XiZhi Wang; HaiTao Liu
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

Review 7.  T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications.

Authors:  Na Li; Jiani Yuan; Wenjia Tian; Lin Meng; Yongyu Liu
Journal:  Cancer Commun (Lond)       Date:  2020-07-17

8.  Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer.

Authors:  Koji Inamori; Yosuke Togashi; Shota Fukuoka; Kiwamu Akagi; Kouetsu Ogasawara; Takuma Irie; Daisuke Motooka; Yoichi Kobayashi; Daisuke Sugiyama; Motohiro Kojima; Norihiko Shiiya; Shota Nakamura; Shoichi Maruyama; Yutaka Suzuki; Masaaki Ito; Hiroyoshi Nishikawa
Journal:  JCI Insight       Date:  2021-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.